S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
7 Stocks That Will Drive the Weight Loss Drugs Market
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
7 Stocks That Will Drive the Weight Loss Drugs Market
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
7 Stocks That Will Drive the Weight Loss Drugs Market
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
7 Stocks That Will Drive the Weight Loss Drugs Market
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
OTCMKTS:BMXMF

bioMérieux (BMXMF) Stock Price, News & Analysis

$108.55
0.00 (0.00%)
(As of 03/27/2024 ET)
Today's Range
$108.55
$108.55
50-Day Range
$106.00
$114.00
52-Week Range
$90.23
$114.00
Volume
N/A
Average Volume
22 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BMXMF stock logo

About bioMérieux Stock (OTCMKTS:BMXMF)

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

BMXMF Stock Price History

BMXMF Stock News Headlines

Biomerieux/adr's Net Worth
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
bioMerieux : du mieux
bioMerieux recule après les annonces
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
See More Headlines
Receive BMXMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for bioMérieux and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:BMXMF
CIK
N/A
Employees
13,800
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.78 billion
Cash Flow
$5.90 per share
Book Value
$32.43 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.88
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Alexandre Merieux (Age 50)
    Executive Chairman
    Comp: $1.51M
  • Mr. Pierre Boulud (Age 53)
    Chief Executive Officer
    Comp: $1.14M
  • Mr. Frederic Beseme (Age 68)
    Head of CSR
    Comp: $24.07k
  • Mr. Guillaume Bouhours (Age 48)
    Executive VP of Purchasing and Information Systems & CFO
  • Sylvain Morgeau
    Investor Relations
  • Ms. Audrey Dauvet (Age 50)
    Executive Vice President of Legal Affairs & Integrity
  • Ms. Valerie Leylde
    Executive Vice President of Human Resources, Communications & CSR
  • Mr. François Lacoste
    Executive Vice President of R&D
  • Mr. Pierre Charbonnier
    Executive Vice President of Global Quality, Manufacturing & Supply Chain
  • Mr. Yasha Mitrotti
    Executive Vice President of Industrial Applications

BMXMF Stock Analysis - Frequently Asked Questions

Should I buy or sell bioMérieux stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for bioMérieux in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BMXMF shares.
View BMXMF analyst ratings
or view top-rated stocks.

How have BMXMF shares performed in 2024?

bioMérieux's stock was trading at $108.50 at the beginning of 2024. Since then, BMXMF shares have increased by 0.0% and is now trading at $108.55.
View the best growth stocks for 2024 here
.

How do I buy shares of bioMérieux?

Shares of BMXMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BMXMF) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners